Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005US20050281786 AAV mediated gene delivery to cochlear cells
12/22/2005US20050281782 Novel recombinant poxvirus composition and uses thereof
12/22/2005US20050281779 Enhancing immune responses to genetic immunization by using a chemokine
12/22/2005US20050281719 Apparatus and method for polymer synthesis using arrays
12/22/2005DE19605657B4 Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats Human proinsulin derivative-encoding DNA, DNA-containing expression vector, transformed with this microorganism and use of this human Proinsulinderivats
12/22/2005DE10344545B4 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
12/22/2005DE10333389A1 Use of cell organelles for stabilizing biomolecules and cells, useful e.g. in cell replication or in vitro translation or transcription systems, particularly mitochondria
12/22/2005DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance
12/22/2005DE10120797B4 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains
12/22/2005CA2573430A1 Anti-perp antibody
12/22/2005CA2570195A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
12/22/2005CA2570033A1 The shine clade of transcription factors and their use
12/22/2005CA2569909A1 Vaccine compositions and methods
12/22/2005CA2569788A1 Tumor specific antibody
12/22/2005CA2569664A1 Lipid encapsulated interfering rna
12/22/2005CA2569645A1 Cationic lipids and methods of use
12/22/2005CA2569511A1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
12/22/2005CA2569419A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2569036A1 Chimeric gapped oligomeric compositions
12/22/2005CA2568995E Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005CA2568735A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2567849A1 Non-recombinant saccharomyces strains that grow on xylose
12/22/2005CA2567793A1 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
12/22/2005CA2567779A1 Improved transformation of soybean
12/22/2005CA2567087A1 Recombinant constructs for use in reducing gene expression
12/22/2005CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide
12/22/2005CA2565888A1 Methods for transforming and expression screening of filamentous fungal cells with a dna library
12/22/2005CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005CA2564784A1 Episomal fusion gene
12/22/2005CA2562773A1 Cholesterol-producing yeast strains and uses thereof
12/22/2005CA2560759A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
12/22/2005CA2546847A1 Methods for the preparation of a fine chemical by fermentation
12/22/2005CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
12/22/2005CA2469139A1 Potato regeneration system and use thereof
12/22/2005CA2469098A1 Pathogen inducible plant promoter and use thereof
12/21/2005EP1607748A1 Microchip, nucleic acid extracting kit, and nucleic acid extracting method
12/21/2005EP1607484A1 Method and circuitry for treating biological material
12/21/2005EP1607483A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use
12/21/2005EP1607482A1 RNAi-based methods for selection of transfected eucaryotic cells
12/21/2005EP1607481A1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
12/21/2005EP1607480A2 Method for synthesizing DNA
12/21/2005EP1607478A2 Chondroitin lyase enzymes
12/21/2005EP1607477A1 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1606417A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
12/21/2005EP1606411A1 Mutant vesicular stomatitis viruses and use thereof
12/21/2005EP1606410A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof
12/21/2005EP1606409A2 Nogo receptor binding protein
12/21/2005EP1606408A2 Human p53 splice variant displaying differential transcriptional activity
12/21/2005EP1606407A2 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/21/2005EP1606406A2 SHORT INTERFERING RNA (siRNA) ANALOGUES
12/21/2005EP1606405A2 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs
12/21/2005EP1606404A2 Phosphokinase assay
12/21/2005EP1606403A2 Hemipteran glutamate decarboxylase
12/21/2005EP1606399A2 Method of screening for target ligands
12/21/2005EP1606398A1 Melan-a peptide analogue-virus-like-particle conjugates
12/21/2005EP1606397A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
12/21/2005EP1606387A2 Vectors used to create hybrid constant regions
12/21/2005EP1606386A2 Removal of plastid sequences by transiently expressed site-specific recombinases
12/21/2005EP1606385A2 Plant production of immunoglobulins with reduced fucosylation
12/21/2005EP1606312A2 Baff mutants with at least one amino acid substitution and methods of their production
12/21/2005EP1606311A1 Interferon-alpha induced gene
12/21/2005EP1606310A2 Secreted protein family
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1606304A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
12/21/2005EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
12/21/2005EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy
12/21/2005EP1606300A2 Sirna libraries optimized for predetermined protein families
12/21/2005EP1606049A1 Method of synthesis and testing of combinatorial libraries using microcapsules
12/21/2005EP1605978A2 Therapeutic compositions
12/21/2005EP1605973A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
12/21/2005EP1605972A2 Hiv-peptide-carrier-conjugates
12/21/2005EP1605971A1 Immunogenic composition and methods
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1546333A4 Aspartyl protease inhibitor as a nematode allergen
12/21/2005EP1539961A4 Improved transporters and their uses
12/21/2005EP1534865A4 Methods and compositions for determining methylation profiles
12/21/2005EP1527182A4 Process for the production of unsaturated fatty acids
12/21/2005EP1511860A4 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains
12/21/2005EP1499738A4 Recombinase polymerase amplification
12/21/2005EP1490496A4 Early inflorescence-preferred regulatory elements and uses thereof
12/21/2005EP1481087A4 Zinc finger libraries
12/21/2005EP1419237A4 Animal model for fatty acid amide-related neurobehaviors
12/21/2005EP1404852B1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
12/21/2005EP1381693A4 Apparatus and method for sequencing a nucleic acid
12/21/2005EP1373534B1 Production of genetically modified plants with puroindolines
12/21/2005EP1337650A4 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1238067B1 Functional genomics using zinc finger proteins
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1180927B1 Transformation of allium sp. with agrobacterium using embryogenic callus cultures
12/21/2005EP1165815B1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
12/21/2005EP1159426B1 Cloning and expression of haemophilus somnus transferrin-binding proteins
12/21/2005EP1155134B1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants